Glimicet-MV 1 Tablet SR
Glimicet-MV 1 Tablet SR
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimison-VM 1 Tablet SR
Unison Pharmaceuticals Pvt Ltd
Voglibose 0.2mg
Pack Size
1 units
Price
Save ₹48
that's 61% off!
About This Medicine
Product description & overview
Glimicet-MV 1 Tablet SR: A Comprehensive Treatment Solution for Type 2 Diabetes
Glimicet-MV 1 Tablet SR combines three key ingredients to effectively manage type 2 diabetes: Glimepiride (1mg), Metformin (500mg), and Voglibose (0.2mg).
This unique formulation offers a comprehensive approach to blood sugar control:
* Glimepiride is a sulfonylurea that stimulates insulin secretion from the pancreas, helping lower blood glucose levels.
* Metformin works by reducing hepatic glucose production and improving insulin sensitivity.
* Voglibose inhibits α-glucosidase enzymes, delaying the absorption of carbohydrates into the bloodstream, further contributing to glycemic control.
Glimicet-MV 1 Tablet SR is a convenient sustained-release tablet that provides steady blood sugar management throughout the day. It's suitable for individuals with Type 2 Diabetes who need help managing their condition effectively and achieving optimal health outcomes. Always consult your healthcare provider before starting or changing any medications.
Note: This description should be used for informational purposes only and does not constitute medical advice.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimicet-MV 1 Tablet SR.
High Risk
Pregnancy
Glimicet-MV 1 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimicet-MV 1 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glimicet-MV 1 Tablet SR may be needed. Please consult your doctor. Glimicet-MV 1 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimicet-MV 1 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimicet-MV 1 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimicet-MV 1 Tablet SR is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glimicet-MV 1 Tablet SR
Products matching your search
Olmezest H 40 Tablet
Olmezest H 40 Tablet
Enzorab 20 Tablet
Enzorab 20 Tablet
G-Triglim 2 Tablet SR
G-Triglim 2 Tablet SR
Olkem 20H Tablet
Olkem 20H Tablet
Enzoxy Max Capsule
Enzoxy Max Capsule
Fepanil-Mef DS Oral Suspension Delicious Orange
Fepanil-Mef DS Oral Suspension Delicious Orange
Foxin Eye Drop
Foxin Eye Drop
Losartas 25 Tablet